Rhumbline Advisers Hutchmed (China) LTD Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Rhumbline Advisers holds 7,553 shares of HCM stock, worth $135,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,553
Previous 6,989
8.07%
Holding current value
$135,954
Previous $117,000
10.26%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HCM
# of Institutions
66Shares Held
8.25MCall Options Held
3.8KPut Options Held
2.4K-
Schroder Investment Management Group London, X03.02MShares$54.4 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.5MShares$27 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$20.7 Million0.33% of portfolio
-
Acadian Asset Management LLC Boston, MA389KShares$7 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny358KShares$6.44 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $3.11B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...